Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04559061 · ClinicalTrials.gov registry record
Vektor vMap™ Clinical Validation Study
A clinical trial, sponsored by Vektor Medical.
- Completed
- Registry status
- 225
- Enrollment target
NCT04559061: Completed study, sponsored by Vektor Medical.
NCT04559061 is a clinical trial that has completed, run by Vektor Medical. The registered enrollment target is 225 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04559061 has completed, sponsored by Vektor Medical.
- COMPLETED
- Registry status
- 225 participants
- Enrollment target
Study Summary
This is a retrospective, multi center clinical study collecting existing, de-identified subject data from medical records to be analyzed using an independent core laboratory to validate performance of a computational ECG mapping system (vMap™).
Interventions
- DEVICE Cardiac ablation procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2021-04-06 |
What the finished NCT04559061 record still lists
NCT04559061 is an observational study that tracks outcomes without assigning an intervention. The registered 225 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Cardiac ablation procedure is the first listed.
NCT04559061 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04559061 about?
NCT04559061 is a clinical study titled "Vektor vMap™ Clinical Validation Study". This is a retrospective, multi center clinical study collecting existing, de-identified subject data from medical records to be analyzed using an independent core laboratory to validate performance of a computational ECG mapping system (vMap™).
What is the current status of trial NCT04559061?
This trial is currently completed. The enrollment target is 225 participants. The study started on 2020-12-01. Estimated completion is 2021-04-06.
What interventions are being tested in trial NCT04559061?
The interventions under investigation include: Cardiac ablation procedure (DEVICE).
Who is sponsoring clinical trial NCT04559061?
This trial is sponsored by Vektor Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03955445 · 225 participants · Phase 3
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
- NCT04054310 · 225 participants · NA
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
- NCT04480554 · 225 participants · Phase 2
Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
- NCT04888104 · 225 participants
Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI